Josh Lamstein

Josh Lamstein is a seasoned entrepreneur and executive with significant experience in the biopharmaceutical and technology sectors. Currently serving as Co-Founder at Valid Inc. and AgileView Inc., Lamstein focuses on advancing drug discovery and synthetic data platforms for AI applications. As Chairman of Scopus BioPharma Inc., Lamstein oversees the development of therapeutics for serious diseases. Additionally, Lamstein holds board positions at Sanctuary, FEED.FM, True Anthem, and previously at Canvs AI, contributing to various innovative projects ranging from mobile apps to algorithmic publishing. As a Partner at KEC Ventures, Lamstein actively engages in early-stage company investments and strategic development. Lamstein's academic background includes an MBA from MIT Sloan School of Management and a BA in Economics and Asian Studies from Colgate University.